# South AMerica Biopsy Devices Market > South America Biopsy Devices Market South America Biopsy Devices Market Research Report: By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others), By End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others) andBy Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.72% - **2018:** $ 264 Million - **2024:** $ 196.7 Million - **2035:** $ 362.74 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Becton Dickinson (US), Hologic (US), Siemens Healthineers (DE), Fujifilm (JP), Cook Medical (US), Olympus (JP), Stryker (US) **Report ID:** MRFR/HC/54675-HCR · **Pages:** 200 · **Author:** Satyendra Maurya · **Last Updated:** May 12, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-america-biopsy-devices-market-56441 --- ## Market Summary **South America Biopsy Devices Market Overview****:** **As per MRFR analysis, the South America Biopsy Devices Market Size was estimated at 264 (USD Million) in 2023.****The South America Biopsy Devices Market Industry is expected to grow from 281(USD Million) in 2024 to 519.9 (USD Million) by 2035. The South America Biopsy Devices Market CAGR (growth rate) is expected to be around 5.753% during the forecast period (2025 - 2035).** **Key South America Biopsy Devices Market Trends Highlighted** The South America Biopsy Devices Market is evolving rapidly, particularly due to the mounting incidence of cancer and related illnesses in the region. South American nations are making government initiatives and investments to improve cancer detection, which is increasing the need for sophisticated biopsy technologies. Enhanced healthcare systems and the focus on early diagnosis are critical for comprehensive exposure to innovative biopsy techniques in both urban and rural regions. There are also other opportunities in the market related to new developments in minimally invasive surgery with higher precision, faster patient recovery, and reduced impact of procedures on body. Investments in medical technologies are growing in emerging South American markets such as Brazil and Argentina, which promotes the development and biomanufacturing of advanced biopsy devices. Also, partnerships between tech companies and healthcare institutions intend to broaden the availability of modern biopsy methods that are important within the country and align with international standards. There is a recent increase in the adoption of imaging techniques for biopsies which improves accuracy during tissue sampling. These new approaches are being increasingly adopted for the diagnosis of different types of cancer, ranging from breast cancer to prostate cancer, and are supported by the region's growing emphasis on personalized medicine. In addition, the incorporation of digital health technologies into the biopsy workflow is a rising trend, enabling improved patient engagement and experience with healthcare. The South American region is rapidly adopting these changes while maintaining low costs which indicates a shift towards improving patient care in the region. **South America Biopsy Devices Market Drivers** Rising Incidence of Cancer The South America Biopsy Devices Market Industry is significantly driven by the rising incidence of cancer across the region. According to the South American Cancer Registry, cancer cases have shown an incremental increase, with a reported 20% rise in new cancer cases over the last decade. Organizations such as the Brazilian Society of Cancerology and the Argentine Society of Oncology have highlighted that lung, breast, and colorectal cancers are among the most prevalent.This surge in the diagnosis of various cancers is bolstering the demand for biopsy devices, as early detection through biopsy procedures is critical for effective treatment planning and improved patient outcomes. Technological Advancements in Biopsy Devices Technological advancements in biopsy techniques and devices are also fueling growth in the South America Biopsy Devices Market Industry. Innovations in minimally invasive procedures, such as image-guided biopsy techniques, have resulted in better precision and reduced recovery times for patients. The introduction of automated biopsy systems in hospitals and clinics in South America has fostered improved diagnostic capabilities, as highlighted in reports from the Technical Institute of Biomedical Technology.These advancements are anticipated to encourage more healthcare providers to adopt these technologies, further driving market expansion. Increasing Investment in Healthcare Infrastructure Investment in healthcare infrastructure in South America is playing a vital role in the growth of the Biopsy Devices Market Industry. The governments of countries like Brazil and Argentina are prioritizing healthcare upgrades, leading to improved access to advanced medical technologies, including biopsy devices. In 2021, Brazilian lawmakers approved a 15% increase in healthcare spending for the next five years, focusing on oncology and diagnostic tools.This increase in funding is expected to facilitate better access to biopsy services, reflecting positively on the market and overall healthcare outcomes in the region. **South America Biopsy Devices Market Segment Insights****:** **Biopsy Devices Market Product Type Insights** The South America Biopsy Devices Market is a vital segment within the healthcare industry that focuses on diagnostic procedures. Among the various product types in this market, Biopsy Guns hold a significant place due to their precision and efficiency in acquiring tissue samples, which is crucial for accurate diagnosis. The growth of this segment reflects the increasing prevalence of diseases requiring biopsy procedures, particularly cancers, which are increasingly affecting populations in South America. Meanwhile, the Biopsy Guidance System segment plays an essential role in improving the accuracy of biopsies, assisting healthcare professionals in targeting specific areas for sampling, thus minimizing patient risk and enhancing procedural success rates.Furthermore, Biopsy Needles are fundamental in the collection of tissue samples and are characterized by their versatility across different types of procedures, making them indispensable in both hospital and outpatient settings. In addition, Biopsy Forceps represent another critical aspect of the market, particularly in procedures needing dexterity and precise tissue handling, thus fostering growth in minimally invasive techniques. The Localization Wires segment is also significant, as these devices assist surgeons in accurately locating tumors or lesions within the body, leading to better surgical outcomes.Other products in the market cater to specialized needs, ensuring a comprehensive offering to healthcare providers. South America is witnessing various trends that are driving the demand for these biopsy devices, including advancements in technology, an increasing focus on early disease detection, and an overall rise in awareness regarding health issues across the region. With an expanding healthcare infrastructure and improvements in medical facilities, the South America Biopsy Devices Market is positioned for continued evolution, with diverse product types addressing the region’s growing healthcare needs. **Biopsy Devices Market Application Insights** The South America Biopsy Devices Market is primarily segmented by Application, which plays a crucial role in diagnosing various types of cancers and other medical conditions. Key applications include Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, and Gynecological Biopsy, each addressing specific health challenges prevalent in the region. Breast Biopsy holds significant importance due to the high incidence of breast cancer among women in South America, while Prostate Biopsy is essential given the rising awareness around male health issues and prostate cancer prevalence.Liver Biopsy is critical due to the increasing cases of liver diseases linked to lifestyle factors like obesity and hepatitis infections. Lung Biopsy is gaining prominence as respiratory diseases, including lung cancer, continue to be of concern in urban areas. Gynecological Biopsy has also seen growth due to the focus on women's health initiatives across countries in South America. This diverse segmentation in the South America Biopsy Devices Market reflects a strong emphasis on specialized medical practices aimed at improving health outcomes and is driven by advancements in medical technology and increasing access to healthcare facilities in the region.The overall market statistics point towards a promising future with continuous developments in biopsy methods that enhance accuracy and reduce patient discomfort. **Biopsy Devices Market Guidance Insights** The Guidance segment of the South America Biopsy Devices Market plays a crucial role in enhancing the accuracy and safety of biopsy procedures across the region. As healthcare infrastructure continues to improve in countries such as Brazil and Argentina, the demand for advanced biopsy techniques is increasing. Ultrasound-Guided Biopsy is significant due to its real-time imaging capabilities, making it a preferred choice among clinicians for soft tissue diagnosis. Stereotactic Guided Biopsy is also gaining traction, particularly for breast biopsies, as its precision is vital for targeting lesions with minimal invasiveness.MRI-Guided Biopsy, while still emerging, is becoming relevant in prostate cancer diagnostics, allowing for targeted sampling of areas of concern identified by advanced imaging technologies. CT Guided Biopsy continues to be important, especially in pulmonary and abdominal areas, by providing detailed cross-sectional images that help in the accurate placement of biopsy needles. The emergence of other guidance methods is significant as they cater to specific clinical needs, driven by technological advancements and patient requirements. The constant evolution within the South America Biopsy Devices Market indicates a positive trend in improving diagnostic accuracy and patient outcomes, supporting the region's healthcare growth and access to specialized medical services. **Biopsy Devices Market End User Insights** The South America Biopsy Devices Market highlights an essential segmentation based on End Users, reflecting a diverse landscape of healthcare facilities and research institutions. Hospitals and Clinics play a significant role in the market due to their direct patient interactions and the urgent care they provide, facilitating a higher demand for biopsy procedures. Diagnostic and Imaging Centers are vital as they specialize in diagnostic services, ensuring precise identification of conditions, which positions them as key players in the utilization of biopsy devices.Academic and Research Institutes contribute to advancements in research and the development of innovative techniques for biopsies, shaping future market trends and bolstering educational efforts in oncology and pathology. The presence of various other facilities, ranging from specialized surgical centers to outpatient care units, adds to the market's robustness by catering to specific patient needs and preferences. The increasing prevalence of cancer and the emphasis on early diagnosis create a favorable environment for these End Users, leading to consistent growth and investment in biopsy technologies across South America. **Biopsy Devices Market Regional Insights** The South America Biopsy Devices Market showcases significant growth across various regions, with Brazil, Mexico, Argentina, and the Rest of South America playing pivotal roles in this expansion. Brazil stands as a major contributor, driven by increasing healthcare investments and a rising prevalence of chronic diseases, which bolster the demand for biopsy procedures. Mexico's healthcare system continues to evolve, enhancing access to biopsy devices and supporting market growth. Argentina exhibits a growing focus on modernizing medical technology, propelling its presence in the biopsy devices segment.The Rest of South America, encompassing a diverse mix of countries, benefits from collaborative health initiatives that stimulate market advancement. This regional segmentation reflects how diverse healthcare needs and economic conditions contribute to the dynamic landscape of the South America Biopsy Devices Market as a whole. With rising patient awareness and advocating advancements in medical technology, particularly in Brazil and Mexico, opportunities for innovation and development in the biopsy devices segment are becoming more pronounced.The market growth in this region aligns with evolving healthcare policies aimed at improving diagnostic capabilities and enhancing patient outcomes. **South America Biopsy Devices Market Key Players and Competitive Insights****:** The competitive landscape of the South America Biopsy Devices Market is characterized by a dynamic interplay of innovation, technology, and strategic partnerships among various players. As the demand for effective diagnostic solutions continues to grow, companies in this sector are increasingly focusing on the development of advanced biopsy devices that cater to a range of medical needs. The market is witnessing innovations addressing minimally invasive procedures, improved accuracy, and patient safety, which are pivotal in enhancing treatment outcomes. The increasing prevalence of cancers and other diseases that necessitate biopsy procedures has prompted key players to invest significantly in research and development, driving competitive dynamics. Moreover, partnerships between device manufacturers and healthcare providers are becoming more prevalent, enabling the introduction of cutting-edge technologies tailored for the unique healthcare challenges of the region. As a result, companies must not only prioritize product quality but also adapt to local regulations and market needs to maintain a competitive edge within this evolving landscape.Focusing on Nuvem Medical, the company has established a solid foothold in the South America Biopsy Devices Market through its innovative approach to product development and strong regional presence. Nuvem Medical is recognized for its emphasis on advanced technology in its biopsy instruments, which enhances precision and minimizes patient discomfort. The company prioritizes user-friendly designs and reliable performance, catering specifically to the needs of healthcare professionals across various medical settings. Its regional specialization enables Nuvem Medical to effectively address the specific challenges faced by the South American healthcare infrastructure. By fostering relationships with local healthcare providers, Nuvem Medical has positioned itself to quickly respond to evolving market demands and trends while maintaining a focus on quality and efficiency in its offerings.Medtronic holds a prominent position in the South America Biopsy Devices Market, known for its extensive portfolio of medical devices and solutions tailored to enhance diagnostic capabilities. Within this market, Medtronic offers a variety of biopsy devices that cater to different medical specialties, emphasizing cutting-edge technology and reliability. The company's strengths lie in its robust research and development capabilities, allowing it to introduce innovative products and solutions that address the unique needs of patients and healthcare providers in South America. Medtronic has also strategically engaged in mergers and acquisitions in the region to broaden its product offerings and market reach, thus reinforcing its competitive standing. Through these initiatives, alongside partnerships with local healthcare organizations, Medtronic is able to leverage its resources to develop advanced biopsy technologies that cater to the diverse healthcare landscape of South America. The firm’s commitment to quality and innovation ensures that it remains at the forefront of the biopsy devices market in this region. **Key Companies in the South America Biopsy Devices Market Include:** Nuvem Medical Medtronic Abbott Laboratories Johnson & Johnson Hologic Cardinal Health Phillips Terumo Corporation Olympus Corporation Stryker Corporation F. HoffmannLa Roche Boston Scientific B. Braun Siemens Healthineers GE Healthcare **South America Biopsy Devices Market Industry Developments** _Recent developments in the South America Biopsy Devices Market have shown significant momentum, particularly driven by advancements in minimally invasive techniques and increasing cancer incidences across the region. Abbott Laboratories is focusing on innovation with a new line of biopsy devices targeted at improving accuracy and reducing patient recovery time. In terms of acquisitions, Medtronic acquired Mazor Robotics in November 2019 to enhance its surgical offerings, a move that is expected to have ripple effects in the biopsy market as they integrate robotic technologies into their device repertoire. Hologic also announced in June 2022 the expansion of their product portfolio to include advanced imaging technology__that complements their existing biopsy equipment. Market growth has been apparent with companies like Boston Scientific observing enhanced sales figures due to rising demand for diagnostic services linked to cancer, emphasizing the growing prevalence of diseases requiring biopsy evaluations. Notably, GE Healthcare made headlines in March 2023 for their collaboration with local health agencies to improve access to diagnostic imaging, notably impacting the adoption rates of biopsy devices in South America._ **South America Biopsy Devices Market Segmentation Insights** **Biopsy Devices Market Product Type****Outlook** **Biopsy Guns** **Biopsy Guidance System** **Biopsy Needles** **Biopsy Forceps** **Localization Wires** **Others** **Biopsy Devices Market Application****Outlook** **Breast Biopsy** **Prostate Biopsy** **Liver Biopsy** **Lung Biopsy** **Gynecological Biopsy** **Others** **Biopsy Devices Market Guidance****Outlook** **Ultrasound-Guided Biopsy** **Stereotactic Guided Biopsy** **MRI-Guided Biopsy** **CT Guided Biopsy** **Others** **Biopsy Devices Market End User****Outlook** **Hospitals & Clinics** **Diagnostic & Imaging Centers** **Academic & Research Institutes** **Others** **Biopsy Devices Market Regional****Outlook** **Brazil** **Mexico** **Argentina** **Rest of South America** **** ## Market Drivers ### Regulatory Support Regulatory support plays a pivotal role in shaping the South America [Biopsy Devices](https://www.marketresearchfuture.com/reports/biopsy-devices-market-2250) Market. Governments in countries such as Brazil and Argentina are implementing policies that facilitate the approval and commercialization of new biopsy technologies. This regulatory environment encourages innovation and investment in the sector. For example, the Brazilian Health Regulatory Agency (ANVISA) has streamlined the approval process for medical devices, which may lead to a faster introduction of advanced biopsy devices into the market. As a result, manufacturers are more inclined to invest in research and development, potentially leading to a wider array of products available to healthcare providers in South America. ### Technological Advancements The South America Biopsy Devices Market is experiencing a surge in technological advancements that enhance the precision and efficiency of biopsy procedures. Innovations such as image-guided biopsies and robotic-assisted systems are becoming increasingly prevalent. For instance, the integration of ultrasound and MRI technologies allows for more accurate targeting of lesions, which is crucial in cancer diagnosis. The market is projected to grow at a compound annual growth rate (CAGR) of approximately 7% over the next five years, driven by these advancements. Furthermore, the development of minimally invasive techniques is likely to reduce patient recovery times, thereby increasing the adoption of biopsy devices across various healthcare settings in South America. ### Growing Healthcare Expenditure The South America Biopsy Devices Market is benefiting from the rising healthcare expenditure across the region. Governments and private sectors are investing more in healthcare infrastructure, which includes the procurement of advanced medical devices. For instance, Brazil's healthcare spending has seen a notable increase, with a focus on improving diagnostic capabilities. This financial commitment is likely to enhance the availability of biopsy devices in hospitals and clinics, thereby facilitating better patient outcomes. As healthcare budgets expand, the market for biopsy devices is expected to flourish, driven by the need for improved diagnostic tools. ### Rising Demand for Early Diagnosis The increasing emphasis on early diagnosis of diseases, particularly cancer, is significantly influencing the South America Biopsy Devices Market. As awareness of the importance of early detection grows, healthcare providers are increasingly adopting biopsy procedures as a standard diagnostic tool. According to recent statistics, the incidence of cancer in South America is projected to rise, necessitating the need for effective diagnostic solutions. This trend is likely to drive the demand for advanced biopsy devices, as they are essential for accurate and timely diagnosis. Consequently, the market is expected to expand as healthcare systems prioritize early intervention strategies. ### Increasing Incidence of Chronic Diseases The rising incidence of chronic diseases, particularly cancer and cardiovascular conditions, is a significant driver of the South America Biopsy Devices Market. As the prevalence of these diseases escalates, the demand for diagnostic procedures, including biopsies, is likely to increase. Recent data indicates that cancer rates in South America are on the rise, prompting healthcare providers to seek effective diagnostic solutions. This trend suggests a growing market for biopsy devices, as they are essential for the accurate diagnosis and management of chronic diseases. Consequently, the industry is poised for growth as healthcare systems adapt to the increasing burden of chronic illnesses. ## Future Outlook The South America Biopsy Devices Market is projected to grow at a CAGR of 5.72% from 2024 to 2035, driven by technological advancements, increasing cancer prevalence, and rising healthcare expenditure. **New opportunities:** - Expansion of telepathology services for remote diagnostics. Development of minimally invasive biopsy techniques to enhance patient comfort. Partnerships with local healthcare providers to improve distribution channels. By 2035, the market is expected to be robust, driven by innovation and strategic partnerships. ## Segment Insights ### By Application: Surgical Biopsy (Largest) vs. Fine Needle Aspiration Biopsy (Fastest-Growing) In the South America Biopsy Devices Market, Surgical Biopsy holds the largest market share, reflecting its extensive use in various medical conditions requiring tissue samples. Core [Needle Biopsy](https://www.marketresearchfuture.com/reports/needle-biopsy-market-3830) and Vacuum-Assisted Biopsy also have significant shares, but they trail behind Surgical Biopsy. Fine Needle Aspiration Biopsy, while smaller in market share, is rapidly gaining traction due to its minimally invasive nature and shorter recovery times, appealing to both healthcare professionals and patients alike. Surgical Biopsy (Dominant) vs. Fine Needle Aspiration Biopsy (Emerging) Surgical Biopsy is considered the dominant force in the South America Biopsy Devices Market due to its established usage in diagnosing cancers and other critical disorders. Its procedures are widely recognized and trusted within medical communities. Conversely, Fine Needle Aspiration Biopsy, characterized by its needle-thin aspiration method, is an emerging choice among clinicians looking for less invasive alternatives. It offers reduced patient discomfort and quicker results, which align with modern healthcare trends emphasizing efficiency and patient satisfaction. As such, Fine Needle Aspiration is rapidly gaining a foothold in various clinical settings across South America. ### By End Use: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing) In the South America Biopsy Devices Market, the end-use segment is significantly dominated by hospitals, which command a substantial portion of the market share. Diagnostic laboratories also have a notable presence, though their impact is growing rapidly. This distribution illustrates the reliance on hospital settings for biopsy procedures, while laboratories are increasingly becoming pivotal through advanced diagnostic capabilities and innovations. The growth trends reveal that the demand for biopsy devices in hospitals is stable, fueled by an increasing patient volume and enhanced healthcare services. Conversely, diagnostic laboratories are witnessing the fastest growth, driven by technological advancements, improved accuracy, and the rising prevalence of chronic diseases that necessitate precise diagnostics and targeted therapies. Hospitals (Dominant) vs. Outpatient Clinics (Emerging) In the South America Biopsy Devices Market, hospitals stand out as the dominant end-use sector due to their comprehensive medical services and access to advanced biopsy technology. They are equipped with specialized personnel, ensuring that biopsy procedures are carried out with optimal accuracy. On the other hand, outpatient clinics are emerging as significant players, primarily due to the increasing trend of minimally invasive procedures and patient preference for swift healthcare solutions. As patients seek convenience and accessibility, outpatient clinics are evolving, offering targeted biopsy services that cater to specific patient needs, appealing to populations seeking cost-effective and efficient care options. ### By Device Type: Needle Biopsy Devices (Largest) vs. Surgical Biopsy Devices (Fastest-Growing) In the South America Biopsy Devices Market, Needle Biopsy Devices hold the largest share, with a significant presence due to their widespread use in various diagnostic procedures. These devices are preferred for their minimally invasive nature and effectiveness in extracting tissue samples for analysis. Surgical Biopsy Devices follow, holding a notable portion of the market as they are essential for more complex biopsies requiring surgical intervention, appealing to surgeons and hospitals for their precision and reliability. The growth of Imaging-Guided Biopsy Devices is noteworthy, driven by advancements in imaging technologies that enhance precision and minimize complications. In contrast, the emerging segment of Biopsy Forceps is gaining traction, especially in outpatient procedures where quick and efficient sample acquisition is necessary. Factors such as increasing cancer incidence and rising awareness of early diagnosis are propelling these segments forward, emphasizing technology's role in improving biopsy outcomes. Needle Biopsy Devices (Dominant) vs. Biopsy Forceps (Emerging) Needle Biopsy Devices dominate the South America Biopsy Devices Market due to their efficiency and widespread application in diagnosing various cancers. These devices utilize thin needles to extract tissue samples with minimal discomfort, making them a preferred choice for many practitioners. Their reliability and accuracy significantly contribute to their market share. On the other hand, Biopsy Forceps are emerging as a key player, especially in outpatient settings. They provide surgeons with the ability to obtain immediate tissue samples during endoscopic procedures. The demand for these forceps is rising as they are perceived to reduce procedural times and enhance patient comfort without compromising diagnostic accuracy. ### By Technology: Ultrasound-Guided Biopsy (Largest) vs. Automated Biopsy Techniques (Fastest-Growing) In the South America Biopsy Devices Market, Ultrasound-Guided Biopsy techniques hold the largest market share due to their widespread use in various medical practices. This technique leverages ultrasound imaging to accurately target tissue samples, providing reliable results and improving patient outcomes. Meanwhile, Automated Biopsy Techniques are gaining traction, appealing to healthcare providers because of their efficiency and precision in sample collection. The growth trends in this segment are largely driven by advancements in medical technology and increasing demand for minimally invasive procedures. Healthcare professionals are increasingly favoring techniques that enhance accuracy while reducing patient recovery times. Additionally, the rising incidence of cancer requires innovative solutions for early detection, thereby driving the adoption of these biopsy techniques across South American countries. Ultrasound-Guided Biopsy (Dominant) vs. Automated Biopsy Techniques (Emerging) Ultrasound-Guided Biopsy stands as a dominant force in the South America Biopsy Devices Market, characterized by its reliability and effectiveness in identifying and targeting lesions. Its application spans various fields, particularly oncology and urology, making it a preferred choice for clinicians. Conversely, Automated Biopsy Techniques are emerging as a vital trend, focusing on enhancing the efficiency of the biopsy process. These techniques utilize robotic-assisted systems that allow for greater accuracy and minimally invasive methods. The shift towards automation in healthcare is fueled by the need for consistent results and reduced procedural time, positioning Automated Biopsy Techniques as a significant player in the future of biopsy procedures. ## Competitive Benchmarking The South America Biopsy Devices Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for early cancer detection and advancements in minimally invasive procedures. Key players such as Medtronic (US), Boston Scientific (US), and Hologic (US) are strategically positioned to leverage innovation and regional expansion to enhance their market presence. Medtronic (US) focuses on integrating advanced imaging technologies into its biopsy devices, while Boston Scientific (US) emphasizes partnerships with local healthcare providers to improve accessibility. Hologic (US) is concentrating on developing next-generation diagnostic tools, which collectively shape a competitive environment that is increasingly reliant on technological advancements and localized strategies. The market structure appears moderately fragmented, with several players vying for market share through various business tactics. Companies are localizing manufacturing to reduce costs and optimize supply chains, which is crucial in a region where logistics can be challenging. This localized approach not only enhances operational efficiency but also allows for quicker responses to market demands. The collective influence of these key players fosters a competitive atmosphere where innovation and strategic partnerships are paramount. In January 2026, Medtronic (US) announced the launch of a new biopsy device that incorporates AI-driven imaging technology, aimed at improving diagnostic accuracy. This strategic move is significant as it positions Medtronic (US) at the forefront of technological innovation in the biopsy sector, potentially enhancing patient outcomes and solidifying its market leadership. The integration of AI into medical devices is likely to become a critical differentiator in the coming years. In December 2025, Boston Scientific (US) expanded its partnership with a leading South American healthcare network to enhance the distribution of its biopsy devices. This collaboration is strategically important as it not only increases market penetration but also aligns with the growing trend of localized healthcare solutions. By working closely with regional providers, Boston Scientific (US) can better tailor its offerings to meet specific market needs, thereby strengthening its competitive position. In November 2025, Hologic (US) secured a significant investment to accelerate the development of its next-generation biopsy systems. This funding is expected to facilitate rapid advancements in technology, particularly in the realm of precision medicine. Hologic's (US) focus on innovation is indicative of a broader trend within the industry, where companies are increasingly prioritizing R&D to stay ahead of competitors and meet evolving healthcare demands. As of February 2026, current competitive trends in the South America Biopsy Devices Market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing product offerings and market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in navigating the complexities of the market. ## Recent News & Developments _Recent developments in the South America Biopsy Devices Market have shown significant momentum, particularly driven by advancements in minimally invasive techniques and increasing cancer incidences across the region. Abbott Laboratories is focusing on innovation with a new line of biopsy devices targeted at improving accuracy and reducing patient recovery time. In terms of acquisitions, Medtronic acquired Mazor Robotics in November 2019 to enhance its surgical offerings, a move that is expected to have ripple effects in the biopsy market as they integrate robotic technologies into their device repertoire. Hologic also announced in June 2022 the expansion of their product portfolio to include advanced imaging technology__that complements their existing biopsy equipment. Market growth has been apparent with companies like Boston Scientific observing enhanced sales figures due to rising demand for diagnostic services linked to cancer, emphasizing the growing prevalence of diseases requiring biopsy evaluations. Notably, GE Healthcare made headlines in March 2023 for their collaboration with local health agencies to improve access to diagnostic imaging, notably impacting the adoption rates of biopsy devices in South America._ ## Report Scope Report Scope: | Report Attribute/Metric Source: | Details | | --- | --- | | MARKET SIZE 2018 | 264.0(USD Million) | | MARKET SIZE 2024 | 281.0(USD Million) | | MARKET SIZE 2035 | 519.9(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.753% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | MARKET FORECAST PERIOD | 2025 - 2035 | | HISTORICAL DATA | 2019 - 2024 | | MARKET FORECAST UNITS | USD Million | | KEY COMPANIES PROFILED | Nuvem Medical, Medtronic, Abbott Laboratories, Johnson & Johnson, Hologic, Cardinal Health, Phillips, Terumo Corporation, Olympus Corporation, Stryker Corporation, F. HoffmannLa Roche, Boston Scientific, B. Braun, Siemens Healthineers, GE Healthcare | | SEGMENTS COVERED | Product Type, Application, Guidance, End User, Regional | | KEY MARKET OPPORTUNITIES | Growing demand for minimally invasive procedures, Increasing cancer prevalence and screenings, Advancements in imaging technologies, Rising healthcare expenditure, Expansion of healthcare infrastructure | | KEY MARKET DYNAMICS | Increasing cancer prevalence, Advancements in device technology, Rising demand for minimally invasive procedures, Growing healthcare expenditure, Expansion of diagnostic capabilities | | COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America | ## Frequently Asked Questions **Q: What is the current valuation of the South America Biopsy Devices Market?** A: As of 2024, the market valuation was 196.7 USD Million. **Q: What is the projected market size for the South America Biopsy Devices Market by 2035?** A: The market is expected to reach a valuation of 362.74 USD Million by 2035. **Q: What is the expected CAGR for the South America Biopsy Devices Market during the forecast period?** A: The market is projected to grow at a CAGR of 5.72% from 2025 to 2035. **Q: Which segment had the highest valuation in the South America Biopsy Devices Market in 2024?** A: The Vacuum-Assisted Biopsy segment had a valuation of 76.7 to 127.74 USD Million in 2024. **Q: What are the key players in the South America Biopsy Devices Market?** A: Key players include Medtronic, Boston Scientific, Becton Dickinson, and Hologic, among others. **Q: Which end-use segment is expected to dominate the market by 2035?** A: The Hospitals segment, valued at 78.68 to 144.82 USD Million in 2024, is likely to remain dominant. **Q: What is the valuation range for Core Needle Biopsy devices in 2024?** A: Core Needle Biopsy devices were valued between 50.0 and 100.0 USD Million in 2024. **Q: How do automated biopsy techniques compare to manual techniques in terms of market valuation?** A: Automated Biopsy Techniques had a valuation range of 49.67 to 92.0 USD Million, compared to 39.34 to 72.0 USD Million for Manual Techniques in 2024. **Q: What is the expected growth trend for imaging-guided biopsy devices by 2035?** A: Imaging-Guided Biopsy Devices, valued at 49.67 to 91.12 USD Million in 2024, are anticipated to grow significantly by 2035. **Q: What is the market valuation for Fine Needle Aspiration Biopsy devices in 2024?** A: Fine Needle Aspiration Biopsy devices were valued between 30.0 and 60.0 USD Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-biopsy-devices-market-56441*